Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgG Antibody”

162 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 162 results

Testing effectiveness (Phase 2)Study completedNCT00904826
What this trial is testing

An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica

Who this might be right for
Neuromyelitis OpticaDevic's Disease
Mayo Clinic 14
Not applicableStudy completedNCT02497885
What this trial is testing

Seroprevalence of MERS-CoV IgG in Healthcare Workers

Who this might be right for
Coronavirus Infections
Ewha Womans University Mokdong Hospital 737
Large-scale testing (Phase 3)UnknownNCT04395170
What this trial is testing

Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Lifefactors Zona Franca, SAS 75
Not applicableTemporarily pausedNCT04408066
What this trial is testing

COVID-19: A POC Test Under Research & Evaluation

Who this might be right for
COVID-19
LumiraDx UK Limited 2,000
Not applicableStudy completedNCT04388072
What this trial is testing

An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
First Affiliated Hospital of Fujian Medical University 200
Not applicableStudy completedNCT03369301
What this trial is testing

The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Who this might be right for
Secondary Immune Deficiency
Octapharma 102
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Post-approval studies (Phase 4)Ended earlyNCT00177970
What this trial is testing

IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
University of Pittsburgh 14
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Testing effectiveness (Phase 2)Looking for participantsNCT07018323
What this trial is testing

Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Who this might be right for
Graves' Disease
Immunovant Sciences GmbH 210
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Not applicableStudy completedNCT05074706
What this trial is testing

Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study

Who this might be right for
Hematologic Diseases
University of Milano Bicocca 700
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Early research (Phase 1)Not Yet RecruitingNCT07486700
What this trial is testing

The Phase I Study of SIG001 Antibody on Cancer Therapy.

Who this might be right for
Neoplams
Peking University 66
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Not applicableWithdrawnNCT05234398
What this trial is testing

TIXAGEVIMAB/CILGAVIMAB Protection of Covid-19 in Transplanted Patients

Who this might be right for
Solid Organ Transplant Recipients
Hospices Civils de Lyon
Early research (Phase 1)Study completedNCT02705638
What this trial is testing

Treatment of IgG4-Related Disease With Revlimid and Rituximab

Who this might be right for
Immunoglobulin G Subclass 4 Related DiseaseIgG4-related DiseaseAutoimmune Pancreatitis+2 more
Mayo Clinic 6
Not applicableLooking for participantsNCT05420935
What this trial is testing

Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room

Who this might be right for
Hypersensitivity, ImmediatePeri-operative InjuryAntibiotic Allergy+1 more
Assistance Publique - Hôpitaux de Paris 40
Not applicableUnknownNCT04470414
What this trial is testing

COVID-19 IgG Antibodies in the Serum of Recovered Patients

Who this might be right for
Covid19
Assiut University 100
Not applicableStudy completedNCT04699903
What this trial is testing

Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood

Who this might be right for
SARS-Cov-2, Covid19
Lumos Diagnostics 201
Load More Results